STOCK TITAN

[SCHEDULE 13G] Reviva Pharmaceuticals Holdings, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G
Rhea-AI Filing Summary

Southern States Bancshares, Inc. (ticker SSBK) has filed a Form 25 with the U.S. Securities and Exchange Commission, jointly submitted by Nasdaq Stock Market LLC on 1 July 2025. The filing formally notifies the SEC of the removal of the company’s common stock from listing and registration under Section 12(b) of the Exchange Act. Nasdaq certifies that it "has reasonable grounds to believe that it meets all of the requirements for filing the Form 25," and both the exchange and issuer state compliance with 17 CFR 240.12d2-2(b) and (c). No financial data, earnings information, or reason for the delisting is provided in the document.

Southern States Bancshares, Inc. (simbolo SSBK) ha presentato un Modulo 25 alla U.S. Securities and Exchange Commission, inviato congiuntamente da Nasdaq Stock Market LLC il 1° luglio 2025. La comunicazione notifica formalmente alla SEC la rimozione delle azioni ordinarie della società dalla quotazione e dalla registrazione ai sensi della Sezione 12(b) del Exchange Act. Nasdaq certifica di avere "motivi ragionevoli per ritenere che siano soddisfatti tutti i requisiti per la presentazione del Modulo 25" e sia la borsa che l'emittente dichiarano la conformità con il 17 CFR 240.12d2-2(b) e (c). Nel documento non sono forniti dati finanziari, informazioni sugli utili o motivazioni per la cancellazione dalla quotazione.

Southern States Bancshares, Inc. (símbolo SSBK) ha presentado un Formulario 25 ante la Comisión de Bolsa y Valores de EE.UU. (SEC), enviado conjuntamente por Nasdaq Stock Market LLC el 1 de julio de 2025. La presentación notifica formalmente a la SEC la eliminación de las acciones ordinarias de la empresa de la cotización y registro bajo la Sección 12(b) de la Exchange Act. Nasdaq certifica que "tiene motivos razonables para creer que cumple con todos los requisitos para presentar el Formulario 25" y tanto la bolsa como el emisor declaran cumplir con el 17 CFR 240.12d2-2(b) y (c). No se proporcionan datos financieros, información de ganancias ni motivo para la exclusión en el documento.

Southern States Bancshares, Inc.(티커 SSBK)는 2025년 7월 1일 Nasdaq Stock Market LLC와 공동으로 미국 증권거래위원회(SEC)에 서식 25를 제출했습니다. 이 제출 서류는 회사의 보통주가 상장 및 등록이 Exchange Act 12(b)조에 따라 취소됨을 SEC에 공식적으로 통지합니다. Nasdaq은 "서식 25 제출 요건을 모두 충족한다고 합리적으로 믿을 만한 근거가 있다"고 인증하며, 거래소와 발행사 모두 17 CFR 240.12d2-2(b) 및 (c)를 준수한다고 명시합니다. 문서에는 재무 데이터, 수익 정보 또는 상장 폐지 사유가 포함되어 있지 않습니다.

Southern States Bancshares, Inc. (symbole SSBK) a déposé un Formulaire 25 auprès de la Securities and Exchange Commission (SEC) des États-Unis, soumis conjointement par Nasdaq Stock Market LLC le 1er juillet 2025. Ce dépôt informe officiellement la SEC du retrait des actions ordinaires de la société de la cotation et de l’enregistrement en vertu de la Section 12(b) du Exchange Act. Nasdaq certifie qu’elle « a des motifs raisonnables de croire que toutes les conditions pour le dépôt du Formulaire 25 sont remplies », et à la fois la bourse et l’émetteur déclarent leur conformité aux 17 CFR 240.12d2-2(b) et (c). Aucun renseignement financier, information sur les bénéfices ou raison du retrait n’est fourni dans le document.

Southern States Bancshares, Inc. (Ticker SSBK) hat am 1. Juli 2025 gemeinsam mit der Nasdaq Stock Market LLC bei der US-Börsenaufsicht SEC ein Formular 25 eingereicht. Die Einreichung informiert die SEC formell über die Entfernung der Stammaktien des Unternehmens von der Börsennotierung und Registrierung gemäß Abschnitt 12(b) des Exchange Act. Nasdaq bestätigt, dass es "vernünftige Gründe hat anzunehmen, dass alle Voraussetzungen für die Einreichung des Formulars 25 erfüllt sind", und sowohl die Börse als auch der Emittent geben die Einhaltung von 17 CFR 240.12d2-2(b) und (c) an. Im Dokument werden keine Finanzdaten, Gewinninformationen oder Gründe für die Delistung angegeben.

Positive
  • None.
Negative
  • SSBK common stock is being removed from listing and registration on Nasdaq under Section 12(b) of the Exchange Act.

Insights

TL;DR: Filing confirms SSBK common shares will cease Nasdaq listing; absence of context leaves investors uncertain.

The Form 25 signals that Southern States Bancshares’ equity will be removed from Nasdaq trading and Section 12(b) registration. While the document affirms procedural compliance with Rule 12d2-2, it lacks any rationale—such as merger, transfer to another exchange, or non-compliance—leaving investors without clarity on next steps. Delistings typically reduce liquidity and can pressure valuation; however, no mitigating information is offered.

TL;DR: Nasdaq and SSBK follow proper rules to voluntarily withdraw the listing.

From a governance standpoint, the exchange certifies it has met all requirements, and the issuer’s voluntary withdrawal appears procedurally sound under 17 CFR 240.12d2-2(c). The involvement of an authorized Nasdaq officer (Tara Petta, AVP) underscores formal compliance. Nonetheless, investors receive no board rationale or shareholder vote details, limiting transparency.

Southern States Bancshares, Inc. (simbolo SSBK) ha presentato un Modulo 25 alla U.S. Securities and Exchange Commission, inviato congiuntamente da Nasdaq Stock Market LLC il 1° luglio 2025. La comunicazione notifica formalmente alla SEC la rimozione delle azioni ordinarie della società dalla quotazione e dalla registrazione ai sensi della Sezione 12(b) del Exchange Act. Nasdaq certifica di avere "motivi ragionevoli per ritenere che siano soddisfatti tutti i requisiti per la presentazione del Modulo 25" e sia la borsa che l'emittente dichiarano la conformità con il 17 CFR 240.12d2-2(b) e (c). Nel documento non sono forniti dati finanziari, informazioni sugli utili o motivazioni per la cancellazione dalla quotazione.

Southern States Bancshares, Inc. (símbolo SSBK) ha presentado un Formulario 25 ante la Comisión de Bolsa y Valores de EE.UU. (SEC), enviado conjuntamente por Nasdaq Stock Market LLC el 1 de julio de 2025. La presentación notifica formalmente a la SEC la eliminación de las acciones ordinarias de la empresa de la cotización y registro bajo la Sección 12(b) de la Exchange Act. Nasdaq certifica que "tiene motivos razonables para creer que cumple con todos los requisitos para presentar el Formulario 25" y tanto la bolsa como el emisor declaran cumplir con el 17 CFR 240.12d2-2(b) y (c). No se proporcionan datos financieros, información de ganancias ni motivo para la exclusión en el documento.

Southern States Bancshares, Inc.(티커 SSBK)는 2025년 7월 1일 Nasdaq Stock Market LLC와 공동으로 미국 증권거래위원회(SEC)에 서식 25를 제출했습니다. 이 제출 서류는 회사의 보통주가 상장 및 등록이 Exchange Act 12(b)조에 따라 취소됨을 SEC에 공식적으로 통지합니다. Nasdaq은 "서식 25 제출 요건을 모두 충족한다고 합리적으로 믿을 만한 근거가 있다"고 인증하며, 거래소와 발행사 모두 17 CFR 240.12d2-2(b) 및 (c)를 준수한다고 명시합니다. 문서에는 재무 데이터, 수익 정보 또는 상장 폐지 사유가 포함되어 있지 않습니다.

Southern States Bancshares, Inc. (symbole SSBK) a déposé un Formulaire 25 auprès de la Securities and Exchange Commission (SEC) des États-Unis, soumis conjointement par Nasdaq Stock Market LLC le 1er juillet 2025. Ce dépôt informe officiellement la SEC du retrait des actions ordinaires de la société de la cotation et de l’enregistrement en vertu de la Section 12(b) du Exchange Act. Nasdaq certifie qu’elle « a des motifs raisonnables de croire que toutes les conditions pour le dépôt du Formulaire 25 sont remplies », et à la fois la bourse et l’émetteur déclarent leur conformité aux 17 CFR 240.12d2-2(b) et (c). Aucun renseignement financier, information sur les bénéfices ou raison du retrait n’est fourni dans le document.

Southern States Bancshares, Inc. (Ticker SSBK) hat am 1. Juli 2025 gemeinsam mit der Nasdaq Stock Market LLC bei der US-Börsenaufsicht SEC ein Formular 25 eingereicht. Die Einreichung informiert die SEC formell über die Entfernung der Stammaktien des Unternehmens von der Börsennotierung und Registrierung gemäß Abschnitt 12(b) des Exchange Act. Nasdaq bestätigt, dass es "vernünftige Gründe hat anzunehmen, dass alle Voraussetzungen für die Einreichung des Formulars 25 erfüllt sind", und sowohl die Börse als auch der Emittent geben die Einhaltung von 17 CFR 240.12d2-2(b) und (c) an. Im Dokument werden keine Finanzdaten, Gewinninformationen oder Gründe für die Delistung angegeben.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: With respect to Row 6 and Row 8 above, Heights Capital Management, Inc. is the investment manager to CVI Investments, Inc. and as such may exercise voting and dispositive power over the shares reported as beneficially owned by CVI Investments, Inc. herein.


SCHEDULE 13G




Comment for Type of Reporting Person: With respect to Row 6 and Row 8 above, Heights Capital Management, Inc. is the investment manager to CVI Investments, Inc. and as such may exercise voting and dispositive power over the shares reported as beneficially owned by CVI Investments, Inc. herein.


SCHEDULE 13G



CVI Investments, Inc.
Signature:/s/ Sarah Travis
Name/Title:Sarah Travis, Assistant General Counsel and Assistant Secretary of Heights Capital Management, Inc.
Date:07/01/2025
Heights Capital Management, Inc.
Signature:/s/ Sarah Travis
Name/Title:Sarah Travis, Assistant General Counsel and Assistant Secretary
Date:07/01/2025

Comments accompanying signature: Heights Capital Management, Inc. serves as authorized agent of CVI Investments, Inc. pursuant to a Limited Power of Attorney, a copy of which is attached as Exhibit I hereto.
Exhibit Information

EXHIBIT INDEX EXHIBIT DESCRIPTION ________ ________ I Limited Power of Attorney II Joint Filing Agreement

FAQ

What does Form 25 mean for Southern States Bancshares (SSBK)?

It is a notification that the company’s common stock will be removed from Nasdaq listing and Section 12(b) registration.

Which security is affected by the delisting?

Common Stock of Southern States Bancshares, Inc.

When was the Form 25 signed?

The document was signed on July 1, 2025.

Who signed the Form 25 on behalf of Nasdaq?

The filing was signed by Tara Petta, AVP of Nasdaq Stock Market LLC.

What regulatory rules are cited for the withdrawal?

Compliance with 17 CFR 240.12d2-2(b) and 17 CFR 240.12d2-2(c) is noted.

Does the filing provide financial or strategic reasons for the delisting?

No. The Form 25 only states procedural compliance and offers no explanation for the delisting.
Reviva Pharmaceutcls Hldgs Inc

NASDAQ:RVPH

RVPH Rankings

RVPH Latest News

RVPH Latest SEC Filings

RVPH Stock Data

51.93M
43.06M
14.3%
29.49%
8.14%
Biotechnology
Pharmaceutical Preparations
Link
United States
CUPERTINO